Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...
Read Full NewsThe U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet to treat infestations caused by the New World screwworm...
Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.
A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.
A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.
Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.
Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...
Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World Health Organization said, as the outbreak of the dangerous...
1.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
2.
Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality
3.
Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.
4.
An inoperable locally advanced NSCLC trial dubbed "Practice Changing".
5.
Study finds 81% of cancer cures touted by TikTok videos are fake
1.
Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies
2.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
3.
From Bench to Bedside: The New Era of Lymphoma Treatment and Education
4.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
5.
A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge